Clinical Trials
3 trialsNCT01989572 2020-07-07
Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery
National Cancer Institute (NCI)
Phase 3 Completed
NCT00680225 2017-04-12
Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal Melanoma
New England Retina Associates
Phase 3 Completed
NCT01974752 2017-01-05
SUMIT
AstraZeneca
Phase 3 Completed